Scientists use CRISPR tools to safely disable gene mutation linked to treatment-resistant melanoma

In a potential advance for melanoma patients, researchers at ChristianaCare’s Gene Editing Institute have used CRISPR gene editing tools to disable a gene mutation often seen in aggressive forms of this dangerous skin cancer that renders promising treatments ineffective.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup